SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 24.99 |
| Enterprise Value ($M) | 26.37 |
| Book Value ($M) | 1.22 |
| Book Value / Share | 0.04 |
| Price / Book | 20.53 |
| NCAV ($M) | -8.42 |
| NCAV / Share | -0.27 |
| Price / NCAV | -2.97 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.14 |
| Return on Assets (ROA) | -0.38 |
| Return on Equity (ROE) | -1.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.60 |
| Current Ratio | 0.71 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 14.43 |
| Assets | 24.07 |
| Liabilities | 22.85 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Asen R Scott | |||
| 13G | Ingalls & Snyder Llc | 8.60 | -66.81 | |
| 13G/A | Lion Point Capital, LP | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 20,902 | 60,637 | 34.47 | |
| 28,970 | 108,228 | 26.77 | |
| 3,490 | 26,484 | 13.18 | |
| 14,075 | 84,233 | 16.71 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DMAC – DiaMedica Therapeutics Inc. | DNTH – Dianthus Therapeutics, Inc. |
| DRMA – Dermata Therapeutics, Inc. | DRUG – Bright Minds Biosciences Inc. |
| DTIL – Precision BioSciences, Inc. |
Financial data and stock pages provided by
Fintel.io